Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
cobolimab (TSR-022)
i
Other names:
TSR-022, TSR 022, WBP 296A, GSK4069889, WBP-296A, WBP296A, GSK-4069889, GSK 4069889, TSR022
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
AnaptysBio, GSK
Drug class:
TIM-3 antagonist
Related drugs:
‹
MBG453 (6)
MBG453 (6)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
IL6 underexpression
Non Small Cell Lung Cancer
IL6 underexpression
Non Small Cell Lung Cancer
dostarlimab-gxly + TSR-022
Sensitive: C3 – Early Trials
dostarlimab-gxly + TSR-022
Sensitive
:
C3
dostarlimab-gxly + TSR-022
Sensitive: C3 – Early Trials
dostarlimab-gxly + TSR-022
Sensitive
:
C3
CXCL8 underexpression
Non Small Cell Lung Cancer
CXCL8 underexpression
Non Small Cell Lung Cancer
dostarlimab-gxly + TSR-022
Sensitive: C3 – Early Trials
dostarlimab-gxly + TSR-022
Sensitive
:
C3
dostarlimab-gxly + TSR-022
Sensitive: C3 – Early Trials
dostarlimab-gxly + TSR-022
Sensitive
:
C3
HAVCR2 overexpression
Non Small Cell Lung Cancer
HAVCR2 overexpression
Non Small Cell Lung Cancer
dostarlimab-gxly + TSR-022
Sensitive: C3 – Early Trials
dostarlimab-gxly + TSR-022
Sensitive
:
C3
dostarlimab-gxly + TSR-022
Sensitive: C3 – Early Trials
dostarlimab-gxly + TSR-022
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login